ArticleIndian journal of thoracic and cardiovascular surgery2025
Quantitative C-reactive protein for differentiating tuberculous and malignant pleural effusion: A cross-sectional study.
Article in Indian journal of thoracic and cardiovascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Pulmonary or pleural tuberculosis and malignancy are the most common causes of lymphocyte-rich pleural effusion. In resource-limited settings, establishing a definitive diagnosis for patients with pleural effusion (PEs) may be challenging, emphasizing the need for a simple diagnostic test. This study aimed to investigate the diagnostic value of quantitative C-reactive protein (qCRP) for differentiating between tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE). Methods: A cross-sectional study was performed on 81 patients admitted for lymphocyte-rich exudative pleural effusion at a tertiary care center. Comprehensive biochemical analyses, including qCRP levels in the pleural fluid and pathological examinations of blood, pleural fluid, and/or tissue, were performed. The t-test was used for continuous variables, and the chi-square test was used for categorical variables. To assess the independent associations between variables, multivariate logistic regression analysis was performed. The diagnostic performance of pleural fluid qCRP levels was evaluated using a receiver operating characteristic (ROC) curve. Results: Forty-four (54.3%) patients were diagnosed with TPE and 34 (42.0%) with MPE. The qCRP levels in the pleural fluid were significantly greater in the TPE group than in the MPE group (55.5 ± 45.9 mg/L vs. 18.6 ± 19.1 mg/L, Conclusions: Pleural fluid qCRP is a simple, rapid, cost-effective diagnostic tool for differentiating tuberculous from malignant etiology in patients with lymphocyte-rich exudative pleural effusion. Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s12055-025-01978-9.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.